Is Biorestorative Therapies Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BRTX) stock is to Strong Buy BRTX stock.
Out of 1 analyst, 1 (100%) are recommending BRTX as a Strong Buy, 0 (0%) are recommending BRTX as a Buy, 0 (0%) are recommending BRTX as a Hold, 0 (0%) are recommending BRTX as a Sell, and 0 (0%) are recommending BRTX as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year BRTX price target, the average BRTX price target is $15.00, with the highest BRTX stock price forecast at $15.00 and the lowest BRTX stock price forecast at $15.00.
The Wall Street analyst predicted that Biorestorative Therapies's share price could reach $15.00 by Dec 7, 2023. The average Biorestorative Therapies stock price prediction forecasts a potential upside of 175.23% from the current BRTX share price of $5.45.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.